Abstract
Dendritic cells (DC) are a heterogeneous population of specialized antigen presenting cells that exhibit complex trafficking properties. DC differentiated in vitro from both peripheral monocytes and CD34+ cells expressed mRNA for platelet activating factor (PAF) receptor. Expression of PAF receptor was increased by TNF alpha, a prototypic inflammatory cytokine that induces differentiation and in vivo mobilization of DC. PAF induced in vitro directional migration of DC obtained from both precursor cells through its specific receptor. Since DC are highly motile cells, protein chemoattractants as well as bioactive phospholipids are likely to contribute to tissue localization of DC, in vivo.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, CD
-
Antigens, CD34
-
Cell Differentiation
-
Chemokine CCL5 / pharmacology
-
Chemotaxis, Leukocyte / drug effects
-
Dendritic Cells / cytology
-
Dendritic Cells / drug effects
-
Dendritic Cells / physiology*
-
Hematopoietic Stem Cells / cytology*
-
Humans
-
Monocytes / cytology*
-
Platelet Activating Factor / pharmacology*
-
Platelet Membrane Glycoproteins / biosynthesis*
-
RNA, Messenger / biosynthesis
-
Receptors, Cell Surface*
-
Receptors, G-Protein-Coupled*
-
Recombinant Proteins / pharmacology
-
Transcription, Genetic* / drug effects
-
Tumor Necrosis Factor-alpha / pharmacology
Substances
-
Antigens, CD
-
Antigens, CD34
-
Chemokine CCL5
-
Platelet Activating Factor
-
Platelet Membrane Glycoproteins
-
RNA, Messenger
-
Receptors, Cell Surface
-
Receptors, G-Protein-Coupled
-
Recombinant Proteins
-
Tumor Necrosis Factor-alpha
-
platelet activating factor receptor